Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

52 results about "Lipid raft" patented technology

The plasma membranes of cells contain combinations of glycosphingolipids, cholesterol and protein receptors organised in glycolipoprotein lipid microdomains termed lipid rafts. Their existence remains very controversial. It has been proposed that they are specialised membrane microdomains which compartmentalise cellular processes by serving as organising centers for the assembly of signaling molecules, allowing a closer interaction of protein receptors and their effectors to promote kinetically favorable interactions necessary for the signal transduction. Lipid rafts influence membrane fluidity and membrane protein trafficking, thereby regulating neurotransmission and receptor trafficking. Lipid rafts are more ordered and tightly packed than the surrounding bilayer, but float freely within the membrane bilayer. Although more common in the cell membrane, lipid rafts have also been reported in other parts of the cell, such as the Golgi apparatus and lysosomes.

Synthetic Lipid Rafts and Methods of Use

Compositions and methods for delivering cargo to cells are provided. One aspect provides a synthetic vesicle containing caveolin 1 or a fragment thereof in an amount effective to form lipid rafts in the vesicle. The synthetic vesicles can be used to deliver polynucleotides, proteins, therapeutic agents, or a combination thereof to specific membrane-bound compartments of a cell. In certain aspects, the synthetic vesicles can deliver cargo to cellular organelles such as mitochondria.
Owner:GENCIA

Chimeric virus-like particles

Chimeric virus-like particles including gag polypeptides are described. Virus-like particles are generated with a gag polypeptide and lipid raft-associated polypeptide linked to an antigen that is not naturally associated with a lipid raft. Preferred methods of generation include expression in insect cells.
Owner:TAKEDA VACCINES INC

Bivalent multifunctional ligands targeting a[beta] oligomers as treatment for alzheimer's disease

Bivalent multifunctional Aβ oligomerization inhibitors (BMAOIs) that target multiple risk factors involved in Alzheimer's disease are provided. The BMAOIs are useful for the treatment and / or prevention of Alzheimer's disease, as well as for diagnostic imaging of Aβ plaques in brain tissue. The BMAOIs comprise i) an Aβ oligomer (ApO)-inhibitor moiety which may have antioxidant activity (e.g. curcumin, curcumin derivatives, curcumin hybrids, resveratrol, etc.); ii) a cell membrane / lipid raft (CM / LR) anchoring moiety (e.g. cholesterol, cholesterylamine, a steroid, etc.); and iii) a spacer or linker moiety that stably links i)
Owner:VIRGINIA COMMONWEALTH UNIV

Dual-channel structure lighting super resolution imaging method and device

ActiveCN105068232AOvercoming the defect that the spatial resolution is limited by the diffraction limitMicroscopesSpatial light modulatorCell membrane
The present invention discloses a dual-channel structure lighting super resolution imaging method and a device. The device comprises an ordinary fluorescent microscope, a light source, a first mirror, a second mirror, a first lens, an aperture, a second lens, a spatial light modulator, a third lens, a light barrier, a fourth lens, a second dichroic mirror, a first band-pass filter, a second band-pass filter, a first detector and a second detector. Meanwhile, the present invention also discloses a microscopic imaging method based on the imaging system. According to the imaging system and the imaging method, the heterogeneity of lipid rafts on a cell membrane can be measured in a hyperspace resolution scale.
Owner:FUJIAN NORMAL UNIV

Phosphoinositide Modulation For The Treatment Of Neurodegenerative Diseases

The present invention relates to the use of agents that inhibit the toxic effects of amyloid oligomers by increasing intracellular levels of phosphoinositol 4-phosphate (PI(4)P, or “PIP”) and / or phosphotidylinositol 4,5-biphosphate (PI(4,5)P2 or “PIP2”), the use of such agents for the treatment of neurodegenerative diseases, methods of treating neurodegenerative diseases by administration of agents which alter lipid metabolism, and methods of identifying agents which alter the association of presenilins with γ-secretase and lipid rafts.
Owner:THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK

Chromatographic column decorated by lipid rafts and preparation method thereof and application in screening of traditional Chinese medicine anti-neoplastic activity sites

The invention discloses a chromatographic column decorated by lipid rafts. The chromatographic column is a silica gel chromatographic column which is decorated with the lipid rafts on the surface. A TrkA lipid raft-sillica gel stationary phase chromatographic system is built firstly. Stationary phase can be combined with medicinal specificity of tyrosine kinase receptors as a target spot, and then reservation is produced, but non-reservation behavior is not existed in the TrkA lipid raft-sillica gel chromatographic column of the tyrosine kinase target spot medicines. Lipid raft-sillica gel chromatograph which is rich in TrkA receptors is a novel medicine screening model which has a living being affiliation character and is capable of selective recognition medicines, wherein the medicines are reacted with the TrkA receptors. The chromatographic system is different from the traditional chromatographic system and has double characters of chromatograph separation and activity recognition. Therefore, the chromatographic system can be used for guide medicine screening study where the TrkA receptors served as drones. The chromatographic column decorated by the lipid rafts is used through different time and different moving phases, and the TrkA lipid raft-sillica gel stationary phase chromatographic system is proved stable. The chromatographic column is good in repeatability, long in service life and has good application prospects. The invention discloses a manufacturing method of the chromatographic column decorated by the lipid rafts.
Owner:JIANGSU UNIV

Bioenergetic bone

A biological composition has a mixture of mechanically selected allogeneic biologic material derived from bone marrow. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.
Owner:VIVEX BIOLOGICS GRP INC

β-Cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases

Methods of reducing the risk of transmission of a sexually transmitted pathogen by contacting the pathogen or cells susceptible to infection by the pathogen with a β-cyclodextrin are provided. Methods for reducing the risk of transmission of a sexually transmitted pathogen to or from a subject by contacting the pathogen or cells susceptible to the pathogen in the subject with a pharmaceutical composition containing a β-cyclodextrin also are provided. Accordingly, pharmaceutical compositions, which include 1) a β-cyclodextrin, which is in an amount that blocks passage of the pathogen through lipid rafts in the membrane of a cell susceptible to the pathogen, and 2) a contraceptive, an agent for treating a sexually transmitted disease, a lubricant, or a combination thereof, are provided, as are composition formulated from a solid substrate that contains an amount of β-cyclodextrin useful for reducing the risk of transmission of a sexually transmitted pathogen.
Owner:THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE

Two-photon dyes for real-time imaging of lipid rafts

Two-photon dyes for real-time imaging of lipid rafts are provided. The two-photon dyes emit fluorescence with high intensity in the environments of cell membranes and can be used to clearly discriminate the hydrophobic and hydrophilic domains of the cell membranes. Therefore, the use of the two-photon dyes enables satisfactory imaging of actual lipid raft domains. In addition, since the two-photon dyes show no cytotoxicity, they can be suitably used in bioimaging applications, for example, real-time imaging of lipid rafts over a long period of time.
Owner:KOREA UNIV RES & BUSINESS FOUND

Methods for Diagnosis and Treatment of Endometrial Cancer

InactiveUS20100196509A1Reduces surface expressionInhibit expressionBiocideCompound screeningENDOMETRIAL NEOPLASIACell Membrane Proteins
The present invention discloses methods of using endothelial membrane protein 2 (EMP2) as a biomarker for stratification of endometrial premalignancy, diagnosing, staging and imaging of endometrial neoplasia. Further, methods for identifying pharmaceutical / therapeutic modalities are described, including compositions which modulate glycolipid-enriched lipid raft microdomains (GEMs).
Owner:MEMORIAL SLOAN KETTERING CANCER CENT +1

Treatment of atherosclerosis

InactiveUS20080025970A1Inhibit bindingOrganic active ingredientsBiocideDiseaseOxidised low density lipoprotein
Inhibitors of the adhesion of monocytes to oxidised low density lipoprotein or other lipid raft ligand for the therapy or prophylaxis of a condition involving monocyte adhesion to oxidised LDL or other lipid raft ligand, such as atherosclerosis, rheumatoid arthritis, multiple sclerosis or glomerulonephritis. An assay for identifying such inhibitors.
Owner:POSTON ROBIN N

Acellular biologic composition and method of manufacture

A biological composition has a mixture of mechanically selected allogeneic biologic material derived from bone marrow. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.
Owner:VIVEX BIOLOGICS GRP INC

Tumor detection kit adopting lamprey Li protein as marker

The invention discloses a tumor detection kit adopting a lamprey Li proteins as a marker. The kit contains a capture reagent and a detection reagent, and the capture reagent and the detection reagentare recombinant lamprey Li proteins capable of specifically marking sugar and sphingomyelin of lipid rafts on the surfaces of tumor cells. The above prepared recombinant protein rLi protein has higherstability, specificity and affinity than antibody molecules, and still keeps complete antigen binding capability and is more sensitive to tumor cell antigens after being stored at 4 DEG C for one year or more when in a dissolved state. The kit has the advantages of high detection sensitivity, convenience in storage and transportation, long validity and low production cost.
Owner:LIAONING NORMAL UNIVERSITY

Fusion protein and application thereof

The invention relates to the technical field of biological pharmaceuticals, in particular to a fusion protein and an application thereof. According to the fusion protein, a plasma membrane positioningsequence, a Dab1 protein, a light-sensitive protein and a fluorescent protein are in fusion to be positioned to a lipid raft region or a non lipid raft region of a cytoplasmic membrane, and through illumination, quick activation and adjustment and control of a PI3K / Akt signal channel can be realized locally at a high time and space resolution. The fusion protein has great important significance in quick effective specific opening and closing control of the signal channel, contributing to understanding a cascade transmission rule of signals and researching diseases closely related to the signal channel.
Owner:SHENZHEN INST OF ADVANCED TECH

Acellular biologic composition and method of manufacture

A biological composition has a mixture of mechanically selected allogeneic biologic material derived from placental tissue. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.
Owner:VIVEX BIOLOGICS GRP INC

Anticholesterol immunoglobulin to treat lipid raft diseases

Immunoreactive compositions and methods for immunizing animal, including, humans, cows, and fowl, against cholesterol and cholesterol derivatives, including cholesterol oxides, and their use in methods for reducing and preventing lipid raft-based diseases, including, but not limited to HIV-1, SARS, prion formation in Creutzfeldt-Jakob disease, and neutralizing oxidized modified lipoproteins, specifically, oxidized-LDL, oxidized-VLDL / IDL, and oxidized-chylomicrons, which contribute to the formation of fatty streaks and atherosclerotic plaques, are described.
Owner:ORIGO FOODS

Vesicle for treating diseases caused by helicobacter pylori

The invention relates to a vesicle for treating diseases caused by Helicobacter pylori infection, wherein the vesicle comprises: a lipid bilayer constituting the main body of the vesicle; cholesterol and helicobacter pylori sensitive antibiotics which are embedded in the lipid bilayer and are used for repairing a host cell lipid raft structure to block immune escape; and caltriol which is used for recovering the degradation effect of autolysosome to kill intracellular helicobacter pylori; wherein the lipid is phospholipid or / and rhamnolipid. The invention also relates to a pharmaceutical composition which comprises the vesicle for treating diseases caused by helicobacter pylori infection and a pharmaceutically acceptable carrier. According to the vesicle disclosed by the invention, the removal rate of helicobacter pylori is further improved by recovering immune response and enhancing the killing effect of intracellular bacteria on the basis of removing pellicle, killing free bacteria and inhibiting readhesion of residual bacteria.
Owner:SUN YAT SEN UNIV

A probe capable of clearly distinguishing and simultaneously imaging cell membrane lipid raft and non-lipid raft microdomains with two fluorescent colors and its application

The invention discloses a single fluorescent probe for clearly distinguishing a cell membrane-lipid raft microdomain from a non-lipid-raft microdomain by using two fluorescence colors in a real-time in-situ manner and simultaneously imaging the microdomains. The fluorescent probe is a compound with a structure shown as a formula (I), wherein R1 expresses 2-ethoxyethyl, aminoalkyl, hydroxyalkyl or alkyl; R2 and R3 express alkyl. The invention also discloses application of the fluorescent probe in marking the lipid raft microdomain and the non-lipid-raft microdomain on a cell membrane of a living cell by using red and green fluorescence colors in the real-time in-situ manner. The probe can mark the lipid raft microdomain by using red fluorescence, and marks the non-lipid-raft microdomain by using green fluorescence at the same time, thereby realizing simultaneous imaging of the two microdomains. Compared with a current commonly-used similar probe laurdan, the probe disclosed by the invention has the characteristics that spectrum difference of two microdomains is greater, so that clear distinguishing and simultaneous imaging of the two microdomains are realized; besides, the internal problems is improved, so the probe is simpler and more convenient to operate during application and is broad in commercial application prospect.
Owner:SHANDONG UNIV

Application of dual-photon fluorescence probe

The invention relates to the technical field of the dual-photon fluorescence probe, and specifically relates to an application of the dual-photon fluorescence probe. The dual-photon fluorescence probeis applied to the cell and tissue imaging and used for detecting lipid raft content and distribution dynamic; the probe can improve the accuracy, precision, sensitivity and imaging resolution of thelipid raft detection, thereby providing a new thought for further preventing and controlling Alzheimer's disease and Prion Disease and like neurodegenerative diseases.
Owner:ZUNYI NORMAL COLLEGE

Applications of transmembrane protein, endoplasmic reticulum liporaft proteins or antagonists or inhibitors of coding genes thereof

The invention discloses applications of transmembrane protein, endoplasmic reticulum liporaft proteins or antagonists or inhibitors of coding genes thereof. Interaction between endoplasmic reticulum lipid raft proteins 1 and 2 (ERLIN1 and ERLIN2) with TM6SF2 and apolipoprotein B (APOB) is found by applying a multi-step affinity purification method in combination with mass spectrometry. The ERLINs and the TM6SF2 stabilize each other, and meanwhile, the TM6SF2 combines with the APOB through the two endoplasmic reticulum lumen sections. Although the ERLINs do not directly combine with the APOB, the APOB can be indirectly stabilized by stabilizing the TM6SF2. The E167K mutation affects the stability of APOB by reducing the TM6SF2 protein level. Reduction of Tm6sf2 or ERLINs protein expression by using adenovirus-associated viruses in mice can reduce APOB protein level in the liver, thereby reducing lipid level in blood. The invention provides a novel target and strategy for treating dyslipidemia.
Owner:SHENZHEN RES INST OF WUHAN UNIVERISTY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products